SIRT3
表观遗传学
组蛋白脱乙酰基酶
锡尔图因
乙酰化
组蛋白脱乙酰基酶5
组蛋白
生物
生物信息学
遗传学
基因
作者
Liu Yu,Xinyi Shen,Mingchang Pang,Zhen Sun,Yongjiang Qian,Wenxin Xue,Zhongqun Wang,Lihua Li
出处
期刊:Life Sciences
[Elsevier]
日期:2021-02-21
卷期号:272: 119178-119178
被引量:18
标识
DOI:10.1016/j.lfs.2021.119178
摘要
Atherosclerosis (AS) is the most common cause of death in cardiovascular diseases and poses severe challenges to human life and safety. Epigenetics plays a vital role in every single link of AS. Whereas, how epigenetics regulates its development and regression is still unknown. Sirt3, a recognized histone deacetylase, having been reported to be involved in other acylation processes in recent years, is broadening its role in epigenetic modifications. Sirt3 is an important factor in the normal physiology of blood vessels through deacetylation of mitochondrial proteins and participates in various metabolic activities. Besides, medical research targeting Sirt3 is in full swing as well. This review combining histone deacetylase Sirt3 with AS, aims to clarify the latest progress in the significant role of Sirt3 in the development and regression of AS and to provide a novel prospect for a new regulatory factor and potential intervention target for AS.
科研通智能强力驱动
Strongly Powered by AbleSci AI